基于共识的欧洲特应性湿疹(特应性皮炎)成人与儿童治疗指南:第二部分
本指南为欧洲跨学科共识指南,综合其他指南、系统评价和已发表研究的证据。第二部分涵盖抗菌治疗、系统治疗、过敏原特异性免疫治疗、补充医学、心身咨询和教育干预。系统免疫抑制治疗(环孢素、甲氨蝶呤、硫唑嘌呤、霉酚酸)是严重难治病例的既定选择;度普利尤单抗可能为安全有效的疾病修饰替代方案;JAK抑制剂和组胺4受体拮抗剂在研发中。
要点
- 环孢素、甲氨蝶呤、硫唑嘌呤和霉酚酸是严重难治病例的既定系统免疫抑制选择,广泛可及。
- 靶向T helper 2通路的生物制剂如度普利尤单抗在可及时可能为安全有效的疾病修饰替代方案。
- 心理应激诱发加重者推荐心身咨询;儿童和成人患者推荐治疗性患者教育(「湿疹学校」)。
核心结论
- 特应性湿疹的管理必须考虑疾病的个体临床变异性。
研究设计与样本
- 本指南为欧洲跨学科联合项目制定的共识指南,纳入相关学科医师和患者,综合其他指南、系统评价和已发表研究的证据。
主要发现
- 环孢素、甲氨蝶呤、硫唑嘌呤和霉酚酸的系统免疫抑制治疗是严重难治病例的既定选择,且广泛可及。
- 靶向T helper 2通路的生物制剂如度普利尤单抗在可及时可能为安全有效的疾病修饰替代方案。
- 口服药物如JAK抑制剂和组胺4受体拮抗剂正在研发中。
- 微生物定植和重叠感染可能导致疾病加重,可能需要额外的抗菌治疗。
- 在选定病例中可考虑针对气传过敏原的过敏原特异性免疫治疗。
关键数值与推荐
- 环孢素、甲氨蝶呤、硫唑嘌呤和霉酚酸是严重难治病例的既定系统免疫抑制选择。
- 度普利尤单抗在可及时可能为安全有效的疾病修饰替代方案。
- 心理应激诱发加重者推荐心身咨询。
- 儿童和成人患者推荐治疗性患者教育(「湿疹学校」)。
- 在选定病例中可考虑针对气传过敏原的过敏原特异性免疫治疗。
临床怎么用
- 严重难治病例可使用环孢素、甲氨蝶呤、硫唑嘌呤或霉酚酸进行系统免疫抑制治疗。
- 在可及时,度普利尤单抗可能作为安全有效的疾病修饰替代方案。
- 心理应激诱发加重者推荐心身咨询,儿童和成人患者推荐治疗性患者教育(「湿疹学校」)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic reviews and published studies into account. This second part of the guideline covers antimicrobial therapy, systemic treatment, allergen-specific immunotherapy, complementary medicine, psychosomatic counselling and educational interventions, whereas the first part covers methods, patient perspective, general measures and avoidance strategies, basic emollient treatment and bathing, dietary intervention, topical anti-inflammatory therapy, phototherapy and antipruritic therapy. Management of AE must consider the individual clinical variability of the disease. Systemic immunosuppressive treatment with cyclosporine, methotrexate, azathioprine and mycophenolic acid is established option for severe refractory cases, and widely available. Biologicals targeting the T helper 2 pathway such as dupilumab may be a safe and effective, disease-modifying alternative when available. Oral drugs such as JAK inhibitors and histamine 4 receptor antagonists are in development. Microbial colonization and superinfection may cause disease exacerbation and can require additional antimicrobial treatment. Allergen-specific immunotherapy with aeroallergens may be considered in selected cases. Psychosomatic counselling is recommended especially in stress-induced exacerbations. Therapeutic patient education ('Eczema school') is recommended for children and adult patients. General measures, basic emollient treatment, bathing, dietary intervention, topical anti-inflammatory therapy, phototherapy and antipruritic therapy have been addressed in the first part of the guideline.
引用
- Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018. PMID: 29878606. doi:10.1111/jdv.14888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。